1-4 of 4
G Forni
Close
Sort by
Journal Articles

A Dose Escalation Study of the Pharmacokinetics, Safety & Efficacy of Deferitrin, an Oral Iron Chelator in Beta Thalassaemia Patients.

R. Galanello, G. Forni, A. Jones, A. Kelly, A. Willemsen, X. He, A. Johnston, D. Fuller, J. Donovan, Antonio Piga
Journal: Blood
Blood (2007) 110 (11): 2669.
https://doi.org/10.1182/blood.V110.11.2669.2669
Published: 2007
Journal Articles

Satisfaction and Convenience of Chelation Therapy in Patients with Sickle Cell Disease (SCD): Comparison between Deferasirox (Exjade ® , ICL670) and Deferoxamine (DFO).

E. Vichinsky, R. Fischer, Z. Pakbaz, O. Onyekwere, J. Porter, P. Swerdlow, T. Coates, P. Lane, B. Files, B.U. Mueller, L. Coïc, G. Forni, L. Abetz, J.F. Baladi, C. Ressayre-Djaffer, I. Gathmann, D. Alberti, P. Marks
Journal: Blood
Blood (2005) 106 (11): 2334.
https://doi.org/10.1182/blood.V106.11.2334.2334
Published: 2005
Journal Articles

Growth and spread of human malignant T lymphoblasts in immunosuppressed nude mice: a model for meningeal leukemia

F Cavallo, M Forni, C Riccardi, A Soleti, F Di Pierro, G Forni
Journal: Blood
Blood (1992) 80 (5): 1279–1283.
https://doi.org/10.1182/blood.V80.5.1279.1279
Published: 1992
Journal Articles

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

R Foa, M Giovarelli, C Jemma, MT Fierro, P Lusso, ML Ferrando, F Lauria, G Forni
Journal: Blood
Blood (1985) 66 (3): 614–619.
https://doi.org/10.1182/blood.V66.3.614.614
Published: 1985